697 related articles for article (PubMed ID: 28760828)
1. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.
Cook C; Carlomagno Y; Gendron TF; Dunmore J; Scheffel K; Stetler C; Davis M; Dickson D; Jarpe M; DeTure M; Petrucelli L
Hum Mol Genet; 2014 Jan; 23(1):104-16. PubMed ID: 23962722
[TBL] [Abstract][Full Text] [Related]
3. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
5. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
Mao CX; Wen X; Jin S; Zhang YQ
Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
[TBL] [Abstract][Full Text] [Related]
6. HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila.
Xiong Y; Zhao K; Wu J; Xu Z; Jin S; Zhang YQ
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4604-9. PubMed ID: 23487739
[TBL] [Abstract][Full Text] [Related]
7. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.
Trzeciakiewicz H; Ajit D; Tseng JH; Chen Y; Ajit A; Tabassum Z; Lobrovich R; Peterson C; Riddick NV; Itano MS; Tripathy A; Moy SS; Lee VMY; Trojanowski JQ; Irwin DJ; Cohen TJ
Nat Commun; 2020 Nov; 11(1):5522. PubMed ID: 33139698
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 6 interacts with the microtubule-associated protein tau.
Ding H; Dolan PJ; Johnson GV
J Neurochem; 2008 Sep; 106(5):2119-30. PubMed ID: 18636984
[TBL] [Abstract][Full Text] [Related]
9. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M
Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423
[TBL] [Abstract][Full Text] [Related]
10. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
Yoshiike Y; Yamashita S; Mizoroki T; Maeda S; Murayama M; Kimura T; Sahara N; Soeda Y; Takashima A
Aging Cell; 2012 Feb; 11(1):51-62. PubMed ID: 21981382
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of tau inhibits its degradation and contributes to tauopathy.
Min SW; Cho SH; Zhou Y; Schroeder S; Haroutunian V; Seeley WW; Huang EJ; Shen Y; Masliah E; Mukherjee C; Meyers D; Cole PA; Ott M; Gan L
Neuron; 2010 Sep; 67(6):953-66. PubMed ID: 20869593
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.
Janczura KJ; Volmar CH; Sartor GC; Rao SJ; Ricciardi NR; Lambert G; Brothers SP; Wahlestedt C
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11148-E11157. PubMed ID: 30397132
[TBL] [Abstract][Full Text] [Related]
13. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
[TBL] [Abstract][Full Text] [Related]
14. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
15. Tau--an inhibitor of deacetylase HDAC6 function.
Perez M; Santa-Maria I; Gomez de Barreda E; Zhu X; Cuadros R; Cabrero JR; Sanchez-Madrid F; Dawson HN; Vitek MP; Perry G; Smith MA; Avila J
J Neurochem; 2009 Jun; 109(6):1756-66. PubMed ID: 19457097
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
[TBL] [Abstract][Full Text] [Related]
17. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
18. Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau.
Jeong H; Shin S; Lee JS; Lee SH; Baik JH; Lim S; Kim YK
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480543
[TBL] [Abstract][Full Text] [Related]
19. Tauopathy: A common mechanism for neurodegeneration and brain aging.
Saha P; Sen N
Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
[TBL] [Abstract][Full Text] [Related]
20. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]